EMEA-001143-PIP01-11-M04
Key facts
Invented name |
|
Active substance |
cabozantinib
|
Therapeutic area |
Oncology
|
Decision number |
P/0357/2022
|
PIP number |
EMEA-001143-PIP01-11-M04
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of solid malignant tumours
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Ipsen Pharma
E-mail: GlobalMedInfo@ipsen.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|